Publications by authors named "Niall Quinn"

100Publications

The "round the houses" sign and "zig-zag" sign in progressive supranuclear palsy and other conditions.

Parkinsonism Relat Disord 2020 Dec 19;81:94-95. Epub 2020 Oct 19.

Centre for Brain Health, Dublin Neurological Institute at the Mater Misericordiae University Hospital, Dublin, Ireland. Electronic address:

View Article and Find Full Text PDF
December 2020

Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions.

Elife 2020 05 28;9. Epub 2020 May 28.

School of Computer Science and Systems Biology Ireland, University College Dublin, Dublin, Ireland.

View Article and Find Full Text PDF
May 2020

Hippocampal α-synuclein pathology correlates with memory impairment in multiple system atrophy.

Brain 2020 06;143(6):1798-1810

Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, 1 Wakefield Street, London WC1N 1PJ, UK.

View Article and Find Full Text PDF
June 2020

What contributes to quality of life in Parkinson's disease: a re-evaluation.

J Neurol Neurosurg Psychiatry 2020 06 5;91(6):563-565. Epub 2020 Mar 5.

UCL Institute of Neurology, University College London, London, UK.

View Article and Find Full Text PDF
June 2020

Multiple system atrophy: the nature of the beast revisited.

Authors:
Niall Quinn

J Neurol Neurosurg Psychiatry 2020 01;91(1):3-4

UCL Institute of Neurology, London WC1N 3BG, UK

View Article and Find Full Text PDF
January 2020

Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment.

Neurology 2019 10;93(14):630-639

From the IRCCS (P.C., G.C.-B., G.G., F.P., L.V.), Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Dipartimento di Scienze Biomediche e Neuromotorie (P.C., G.C.-B., G.G., P.M., F.P.), Università di Bologna, Bologna, Italy; Department of Neurology (E.E.B., P.A.L.), Mayo Clinic, Rochester, MN; Multidisciplinary Sleep Unit (A.I.), Neurology Service, Hospital Clinic de Barcelona, IDIBAPS CIBERNED, Barcelona, Spain; UCL Queen Square Institute of Neurology (N.Q.), Queen Square, London; Parkinson's Disease and Movement Disorders Unit (E.T.), Neurology Service, Hospital Clinic de Barcelona; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) (E.T.), University of Barcelona (UB), and Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain; Department of Neurology (G.K.W.), Innsbruck Medical University, Innsbruck, Austria; Department of Neuroscience (G.A.), Rehabilitation, Ophthalmology, Genetics and Maternal Child Health, University of Genoa, Genoa, Italy; The Multiple System Atrophy Coalition, Inc. (P.B.), Charlotte, NC; Neurophysiopathology Unit (E.A.), IRCCS "C. Mondino" Foundation, Pavia, Italy; Department of Clinical Neurophysiology (I.G.), CHU de Bordeaux, Bordeaux, France; Université de Bordeaux (I.G.), Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, Bordeaux, France; CNRS (I.G.), Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, Bordeaux, France; Department of Neurology (T.O.), Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minami Uonuma, Niigata, Japan; Parkinson's Disease and Movement Disorders Unit (C.P., N.G.P.), IRCCS "C. Mondino" Foundation, Pavia; Dipartimento di Medicina Specialistica (C.V.), Diagnostica e Sperimentale (DIMES), University of Bologna, Bologna, Italy; Dipartimento di Scienze biomediche e chirurgico specialistiche (C.V.), University of Ferrara, Ferrara, Italy; Department of Neurosciences (A.A.), University of Padua, Padua, Italy; Department of Clinical and Motor Neuroscience (A.P.B.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Spinal Unit (J.B.), Montecatone Rehabilitation Institute, Imola, Italy; Department of Neurology (H.K.), New York University School of Medicine, New York, NY; Department of Medicine (M.T.P.), Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy; "Luigi Sacco" Department of Biomedical and Clinical Sciences (N.P., A.S.), University of Milan, Milan, Italy; Service de Neurologie (F.T., W.G.M.), CRMR Atrophie Multisystématisée, CHU Bordeaux, Bordeaux, France; Univ. de Bordeaux (F.T., W.G.M.), Institut des Maladies Neurodégénératives, Bordeaux, France; and Department Medicine (W.G.M.), University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand.

View Article and Find Full Text PDF
October 2019

Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.

Brain 2019 09;142(9):2813-2827

Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, 1 Wakefield Street, London, UK.

View Article and Find Full Text PDF
September 2019

New estimates of flood exposure in developing countries using high-resolution population data.

Nat Commun 2019 04 18;10(1):1814. Epub 2019 Apr 18.

Fathom, The Engine Shed, Station Approach, Bristol, BS1 6QH, UK.

View Article and Find Full Text PDF
April 2019

Soft signs in movement disorders: friends or foes?

J Neurol Neurosurg Psychiatry 2019 08 8;90(8):961-962. Epub 2018 Nov 8.

Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital - UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada

View Article and Find Full Text PDF
August 2019

Ciliary dynein motor preassembly is regulated by Wdr92 in association with HSP90 co-chaperone, R2TP.

J Cell Biol 2018 07 9;217(7):2583-2598. Epub 2018 May 9.

Centre for Discovery Brain Sciences, Edinburgh Medical School, University of Edinburgh, Edinburgh, Scotland, UK

View Article and Find Full Text PDF
July 2018

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Neurology 2018 01 13;90(2):74-82. Epub 2017 Dec 13.

From Muhammad Ali Parkinson Center (R.R.W.), Barrow Neurological Institute, Phoenix, AZ; Department of Neurology (F.K., G.K.W., W.P., K.S., N.S.), Medical University Innsbruck, Austria; National Institute of Neurological Disorders and Stroke (W.R.G., W.J.K.), NIH, Bethesda, MD; Department of Neurology (P.A.L.), Mayo Clinic, Rochester, MN; Brain and Mind Centre (G.H.), Sydney Medical School, the University of Sydney; UNSW Medicine & Neuroscience Research Australia (G.H.), Sydney; Queen Square Brain Bank (J.H.), UCL Institute of Neurology (N.P.Q.), London, UK; UPS, INSERM, and CHU de Toulouse (O.R.), University de Toulouse; Centre de Référence Maladie Rare contre l'AMS (O.R.), Centre d'Investigation Clinique CIC1436, Départments de Pharmacologie Clinique et de Neurosciences, NeuroToul/COEN Center of Excellence in Neurodegeneration, Toulouse, France; Department of Pathology & Laboratory Medicine (L.M.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Manhasset, NY; The Multiple System Atrophy (MSA) Coalition, Inc. (P. B., J.B., P.F., L.K., C.L., C.R., S.S.), Charlotte, NC; Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Las Vegas, NV; Medical Affairs (V.A.), Teva Pharmaceuticals, Frazer, PA; Department of Neurology (G.B.), David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles; Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK; Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, Grand Rapids, MI; Center for Neurological Restoration (H.F.), Cleveland Clinic, OH; Defeat MSA (P.F.); MSA Shoe Charity (P.F., C.R.), Saint Clair Shores, MI; Department of Neurology (R.F.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Neurodegenerative Diseases (T.G.), Hertie Institute of Clinical Brain Research, University of Tübingen; German Center for Neurodegenerative Diseases (DZNE) (T.G.), Tübingen, Germany; Lundbeck LLC (A.H.), Deerfield, IL; German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Munich; Department of Neurology (G.U.H.), Technical University of Munich, Germany; Neurogenomics Division (M.J.H.), The Translational Genomics Research Institute, Phoenix, AZ; Dandrite & Department of Biomedicine (P.H.J.), Aarhus University, Denmark; Quanterix (A.J.), Lexington, MA; Department of Neurology (U.J.K.), Columbia University Medical Center; Department of Neurology (H.K.), New York University School of Medicine, New York; Whitehead Institute for Biomedical Research (V.K.), Cambridge; Ann Romney Center for Neurologic Disease (V.K.), Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard Stem Cell Institute (V.K.), Cambridge, MA; Department of Neurology (T.K.), University of Bonn; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Bonn, Germany; Brain and Mind Centre (W.S.K.), Sydney Medical School, University of Sydney, Australia; Department of Neurology (P.L.), Henry Ford Hospital; Department of Neurology (P.L.), Wayne State University School of Medicine, Detroit, MI; Division of Neurosciences (E.M.), National Institute on Aging/NIH, Bethesda, MD; Centre de Référence Maladie Rare AMS (W.M.), Hôpital Pellegrin, CHU de Bordeaux; Université de Bordeaux (W.M.), Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux; Paris Saclay Institute of Neuroscience (R.M.), CNRS, Gif-sur-Yvette, France; Genentech Inc. (S.O.), South San Francisco; Cedars-Sinai Medical Center (S.P.), Los Angeles, CA; Department of Neurology (D.R.), Vanderbilt University Medical Center, Nashville, TN; MSA NJ (C.R.), Howell, NJ; Prothena Biosciences (D.S.), South San Francisco, CA; Division of Neurology (M.S.), Department of Medicine, The Ottawa Hospital, Canada; Department of Neurology (J.D.S.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Cure MSA Foundation (L.S.), Fremont, CA; Avid Radiopharmaceuticals (A.S.), Philadelphia, PA; Department of Neurological Sciences (G.T.S.), Rush University Medical Center, Chicago, IL; Department of Neurology (S.T.), Graduate School of Medicine, Tokyo University, Tokyo, Japan; and University of Washington (J.Z.), Seattle. W.R.G. is currently affiliated with Janssen Research and Development, Titusville, NJ.

View Article and Find Full Text PDF
January 2018

IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks.

Sci Signal 2017 Dec 5;10(508). Epub 2017 Dec 5.

Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK.

View Article and Find Full Text PDF
December 2017

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers).

Qual Life Res 2016 Jan 12;25(1):81-8. Epub 2015 Aug 12.

Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK.

View Article and Find Full Text PDF
January 2016

ADCY5 mutations are another cause of benign hereditary chorea.

Neurology 2015 Jul 17;85(1):80-8. Epub 2015 Jun 17.

From the Department of Molecular Neuroscience (N.E.M., S.W., J.H., M.R., H.H., N.W.W.) and Sobell Department of Motor Neuroscience and Movement Disorders (R.E., B.B., C.G., M.S., N.Q., K.P.B.), UCL Institute of Neurology, London, UK; IRCCS Istituto Auxologico Italiano (N.E.M.), Department of Neurology and Laboratory of Neuroscience-Department of Pathophysiology and Transplantation, "Dino Ferrari" Centre, Università degli Studi di Milano; Dipartimento di Scienze Neurologiche e del Movimento (R.E.), Università di Verona, Italy; Department of Neurology (B.B.), University Hospital Heidelberg; Department of Neurology (C.G.), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Neurology Clinic (M.S.), Attiko Hospital, University of Athens; and Movement Disorders Department (M.S.), Hygeia Hospital, Athens, Greece.

View Article and Find Full Text PDF
July 2015

What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.

J Neurol Neurosurg Psychiatry 2016 Mar 19;87(3):319-23. Epub 2015 May 19.

Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, UK.

View Article and Find Full Text PDF
March 2016

A short clinical history of multiple system atrophy.

Authors:
Niall Quinn

Clin Auton Res 2015 Feb 13;25(1):3-7. Epub 2015 Jan 13.

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK,

View Article and Find Full Text PDF
February 2015

H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?

Mov Disord 2015 May 27;30(6):828-33. Epub 2014 Dec 27.

Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, United Kingdom.

View Article and Find Full Text PDF
May 2015

Markedly asymmetric presentation in multiple system atrophy.

Parkinsonism Relat Disord 2013 Oct 6;19(10):901-5. Epub 2013 Jun 6.

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, United Kingdom.

View Article and Find Full Text PDF
October 2013

"Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.

Mov Disord 2013 Aug 29;28(9):1184-99. Epub 2013 May 29.

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, UK.

View Article and Find Full Text PDF
August 2013

Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts.

Sci Transl Med 2012 Apr;4(128):128ra41

Centre for Neuroscience, Division of Experimental Medicine, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK.

View Article and Find Full Text PDF
April 2012

Difference in MSA phenotype distribution between populations: genetics or environment?

J Parkinsons Dis 2012 ;2(1):7-18

Queen Square Brain Bank for Neurological Disorders, UCL Institute of Neurology, Queen Square, University College London, London, UK.

View Article and Find Full Text PDF
June 2014

Fragile X-associated tremor ataxia syndrome sine tremor.

Mov Disord 2011 Aug 31;26(10):1960-2. Epub 2011 May 31.

View Article and Find Full Text PDF
August 2011

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.

Mov Disord 2011 Sep 24;26(11):1997-2003. Epub 2011 May 24.

Centre for Neuroscience, Division of Experimental Medicine, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London, United Kingdom.

View Article and Find Full Text PDF
September 2011

Deep brain stimulation effects in dystonia: time course of electrophysiological changes in early treatment.

Mov Disord 2011 Aug 5;26(10):1913-21. Epub 2011 May 5.

Sobell Department of Motor Neuroscience and Movement Disorders, UCL-Institute of Neurology, University College London, London, United Kingdom.

View Article and Find Full Text PDF
August 2011

Tremor--some controversial aspects.

Mov Disord 2011 Jan 10;26(1):18-23. Epub 2010 Dec 10.

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article and Find Full Text PDF
January 2011

Nonmotor symptoms in Parkin gene-related parkinsonism.

Mov Disord 2010 Jul;25(9):1279-84

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article and Find Full Text PDF
July 2010

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.

Sci Transl Med 2010 Jun;2(38):38ra46

Centre for Neuroscience, Division of Experimental Medicine, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK.

View Article and Find Full Text PDF
June 2010

ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.

Mov Disord 2010 Jun;25(8):979-84

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article and Find Full Text PDF
June 2010

Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.

Brain 2010 Mar;133(Pt 3):727-45

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, UK.

View Article and Find Full Text PDF
March 2010

Reckless generosity in Parkinson's disease.

Mov Disord 2010 Jan;25(2):221-3

Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London, London, United Kingdom.

View Article and Find Full Text PDF
January 2010

The clinical approach to movement disorders.

Nat Rev Neurol 2010 Jan;6(1):29-37

Parkinson Centre Nijmegen (ParC), Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

View Article and Find Full Text PDF
January 2010

In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study.

Exp Neurol 2010 Mar 4;222(1):120-4. Epub 2010 Jan 4.

MRC Clinical Science Centre and Division of Neuroscience and Mental Health, Imperial College, London, UK.

View Article and Find Full Text PDF
March 2010

A validation exercise on the new consensus criteria for multiple system atrophy.

Mov Disord 2009 Nov;24(15):2272-6

National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.

View Article and Find Full Text PDF
November 2009

GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias.

Mov Disord 2009 Aug;24(11):1684-8

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom.

View Article and Find Full Text PDF
August 2009

Comparative responsiveness of Parkinson's disease scales to change over time.

Mov Disord 2009 Apr;24(6):813-8

Department of Clinical Neurosciences, Royal Free Hospital, University College, Rowland Hill Street, London, UK.

View Article and Find Full Text PDF
April 2009

Unusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer's cramp.

Mov Disord 2008 Oct;23(13):1913-5

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom.

View Article and Find Full Text PDF
October 2008

Quality of life in Parkinson's disease: the relative importance of the symptoms.

Mov Disord 2008 Jul;23(10):1428-34

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology and the National Hospital for Neurology and Neurosurgery, University College London, Queen Square, London, United Kingdom.

View Article and Find Full Text PDF
July 2008

Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients.

Mov Disord 2008 May;23(7):977-984

Department of Neuro-otology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.

View Article and Find Full Text PDF
May 2008

Antineuronal antibodies in Parkinson's disease.

Mov Disord 2008 May;23(7):958-963

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article and Find Full Text PDF
May 2008

Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years.

Mov Disord 2008 Feb;23(3):416-21

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom.

View Article and Find Full Text PDF
February 2008

Survival in multiple system atrophy.

Mov Disord 2008 Jan;23(2):294-6

Department of Clinical Neurosciences, Royal Free & University College Medical School, London, United Kingdom.

View Article and Find Full Text PDF
January 2008

Paroxysmal dyskinesia with interictal myoclonus and dystonia: a report of two cases.

Parkinsonism Relat Disord 2008 26;14(3):250-2. Epub 2007 Nov 26.

Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London WC1N 3BG, UK.

View Article and Find Full Text PDF
August 2008

The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases.

Mov Disord 2008 Jan;23(1):107-13

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom.

View Article and Find Full Text PDF
January 2008

The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy.

Mov Disord 2007 Dec;22(16):2325-31

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article and Find Full Text PDF
December 2007

Measuring health-related quality of life in MSA: the MSA-QoL.

Mov Disord 2007 Dec;22(16):2332-8

Department of Clinical Neurosciences, Royal Free and University College Medical School, University College London, London, United Kingdom.

View Article and Find Full Text PDF
December 2007

Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs).

Mov Disord 2007 Nov;22(15):2210-5

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom.

View Article and Find Full Text PDF
November 2007

Primary lateral sclerosis mimicking atypical parkinsonism.

Mov Disord 2007 Oct;22(14):2057-62

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article and Find Full Text PDF
October 2007

Pallidal stimulation modifies after-effects of paired associative stimulation on motor cortex excitability in primary generalised dystonia.

Exp Neurol 2007 Jul 4;206(1):80-5. Epub 2007 Apr 4.

Unit of Functional Neurosurgery, Sobell Department Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, Box 146 8-11 Queen Square, London WC1N 3BG, UK.

View Article and Find Full Text PDF
July 2007

Rate of clinical progression in Parkinson's disease. A prospective study.

Mov Disord 2007 May;22(7):938-45

Department of Clinical Neurosciences, Royal Free Hospital, University College London, London, United Kingdom.

View Article and Find Full Text PDF
May 2007

The entity of young onset primary cervical dystonia.

Mov Disord 2007 Apr;22(6):843-7

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom.

View Article and Find Full Text PDF
April 2007

Changes in blink reflex excitability after globus pallidus internus stimulation for dystonia.

Mov Disord 2006 Oct;21(10):1650-5

Unit of Functional Neurosurgery, Sobell Department Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article and Find Full Text PDF
October 2006

Atypical movement disorders in antiphospholipid syndrome.

Mov Disord 2006 Jul;21(7):944-9

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article and Find Full Text PDF
July 2006

Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.

Mov Disord 2006 Jun;21(6):783-8

MRC Clinical Science Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom.

View Article and Find Full Text PDF
June 2006

Adult-onset primary lower limb dystonia.

Mov Disord 2006 Jun;21(6):767-71

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom.

View Article and Find Full Text PDF
June 2006

Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability.

Parkinsonism Relat Disord 2006 Jan 3;12(1):35-41. Epub 2005 Nov 3.

Royal Free and University College Medical School, University College London NW3 2PF, London, UK.

View Article and Find Full Text PDF
January 2006

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.

Brain 2005 Dec 24;128(Pt 12):2977-86. Epub 2005 Oct 24.

MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK.

View Article and Find Full Text PDF
December 2005

Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.

Mov Disord 2006 Mar;21(3):299-305

MRC Clinical Sciences Centre, Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom.

View Article and Find Full Text PDF
March 2006